NYSE
$3.61▼ 0.82%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $389.2MShares out 1.100M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
7- 10.9After-hours26.10.10 05:588-KKey event#●●●
IMPACT BIOMEDICAL INC.
Impact BioMedical Inc. effected a 1-for-12.62 reverse stock split effective September 23, 2026. As a result of this action, the total number of issued and outstanding common shares was reduced from approximately 107.8 million to approximately 8.6 million.…more
$3.61-0.82%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.24After-hours26.09.25 08:374Ownership
IMPACT BIOMEDICAL INC.
DSS, INC. has filed a Form 4 reporting a change in beneficial ownership of securities in IMPACT BIOMEDICAL INC. The filing details the transaction that occurred on September 22, 2026.…more
$3.61-0.82%vs prev closeView filingShare - 9.18Overnight26.09.17 07:08filed425Other
IMPACT BIOMEDICAL INC.
Impact Biomedical Inc. filed a Form F-4 registration statement with the SEC on September 10, 2026, in connection with its proposed merger with Zoar Limited. The completion of this business combination remains subject to customary closing conditions, including shareholder approval, the effectiveness of the registration statement, and approval for listing on the NYSE American.…more
$3.61-0.82%vs prev closeView filingShare
6 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.16Pre-market26.09.16 22:20#●●●#●●●
Impact Biomedical Files F-4 Registration Statement for Merger with Zoar Ltd.…more
Impact Biomedical has filed a Form F-4 registration statement with the SEC to advance its proposed business combination with Zoar Ltd. The completion of the merger remains subject to shareholder approval and other customary closing conditions.…more
$3.61-0.82%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.15Overnight26.09.15 10:26
●●●●●●●● ●●●●● ●●●●●●
Impact BioMedical is implementing a 1-for-12.62 reverse stock split to support its proposed merger with Zoar Limited and meet continued-listing requirements. This action does not guarantee the completion of the merger or compliance with exchange listing standards.…more
$3.61-0.82%vs prev close - 9.11After-hours26.09.12 05:05
●●●●●●●● ●●●●● ●●●●●●
Impact BioMedical will implement a 1-for-12.62 reverse stock split to support its continued listing and proposed business combination. The move will reduce the company's outstanding shares from approximately 107.8 million to 8.54 million.…more
$3.61-0.82%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report